Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

NCT06253117 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Acute Pancreatitis

Interventions

DRUG: Pirfenidone
DRUG: Placebo

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]